Saturday, 22 May 2010

Fada Loperamida




Fada Loperamida may be available in the countries listed below.


Ingredient matches for Fada Loperamida



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Fada Loperamida in the following countries:


  • Argentina

International Drug Name Search

Friday, 21 May 2010

Medezol




Medezol may be available in the countries listed below.


Ingredient matches for Medezol



Ketoconazole

Ketoconazole is reported as an ingredient of Medezol in the following countries:


  • Spain

International Drug Name Search

Thursday, 20 May 2010

Silverzine




Silverzine may be available in the countries listed below.


Ingredient matches for Silverzine



Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silverzine in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 18 May 2010

Sveltanet




Sveltanet may be available in the countries listed below.


Ingredient matches for Sveltanet



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Sveltanet in the following countries:


  • Greece

International Drug Name Search

Monday, 17 May 2010

Sodium Nitroprusside BP




Sodium Nitroprusside BP may be available in the countries listed below.


Ingredient matches for Sodium Nitroprusside BP



Nitroprusside

Sodium Nitroprusside is reported as an ingredient of Sodium Nitroprusside BP in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Friday, 14 May 2010

Carboplatin




In some countries, this medicine may only be approved for veterinary use.


In the US, Carboplatin (carboplatin systemic) is a member of the drug class alkylating agents and is used to treat Cancer, Cervical Cancer and Ovarian Cancer.

US matches:

  • Carboplatin

  • Carboplatin Intravenous

UK matches:

  • Carboplatin 10 mg/ml Intravenous Infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XA02

CAS registry number (Chemical Abstracts Service)

0041575-94-4

Chemical Formula

C6-H12-N2-O4-Pt

Molecular Weight

371

Therapeutic Category

Antineoplastic agent

Chemical Name

Platinum, diamine[1,1-cyclobutanedicarboxylato(2-)]-, (SP-4-2)-

Foreign Names

  • Carboplatinum (Latin)
  • Carboplatin (German)
  • Carboplatine (French)
  • Carboplatino (Spanish)

Generic Names

  • Carboplatin (OS: JAN, USAN, BAN)
  • Carboplatine (OS: DCF)
  • Carboplatino (OS: DCIT)
  • CBDCA (IS)
  • IM-8 (IS)
  • JM-8 (IS: Bristol-Myers)
  • NSC 241240 (IS)
  • Carboplatin (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Carboplatine (PH: Ph. Eur. 6)
  • Carboplatinum (PH: Ph. Eur. 6)

Brand Names

  • Actoplatin
    Actavis, Indonesia


  • Axicarb
    Axios, Germany


  • Bagotanilo
    Armstrong, Mexico


  • Bioplatinex
    Biogalenic, Venezuela


  • Blastocarb
    Lemery, Mexico; Lemery, Peru


  • Carbo-cell
    Cell pharm, Germany


  • Carbokebir
    Aspen, Argentina


  • Carbomedac
    Medac, Germany; Medac, Finland


  • Carbomerck
    Mylan Pharmaceutical, Japan; Nippon Kayaku, Japan


  • Carboplamin
    Vianex / BIANEΞ, Greece


  • Carboplan
    Vianex / BIANEΞ, Greece


  • Carboplat
    Asofarma, Mexico


  • Carboplatin Abic
    Abic, Hong Kong


  • Carboplatin Actavis
    Actavis, Austria; Actavis, Switzerland


  • Carboplatin Alvia
    Alvia, Greece


  • Carboplatin Amphar
    Atafarm, Turkey


  • Carboplatin Bendalis
    Bendalis, Germany


  • Carboplatin BMM Pharma
    BMM Pharma, Sweden


  • Carboplatin DBL
    Hospira, Indonesia; Hospira, New Zealand; Hospira, Singapore; Mayne, Hong Kong; Mayne, Malaysia; Orna, Turkey; Tempo Scan Pacific, Indonesia


  • Carboplatin Ebewe
    Ebewe, Austria; Ebewe, Bulgaria; Ebewe, Czech Republic; Ebewe, Estonia; Ebewe, Georgia; Ebewe, Hungary; Ebewe, Indonesia; Ebewe, Israel; Ebewe, Lithuania; Ebewe, Latvia; Ebewe, Myanmar; Ebewe, Poland; Ebewe, Serbia; Ebewe, Russian Federation; Ebewe, Slovenia; Ebewe, Tunisia; Ebewe, Vietnam; Ebewe Pharma, Slovakia; Ferron, Indonesia; InterPharma, New Zealand; Liba, Turkey; Meda, Finland; OncoCorp, Germany; Pharmanel, Greece; Sandoz, Switzerland; Würth, Croatia (Hrvatska)


  • Carboplatin Gerolymatos
    png Gerolymatos, Greece


  • Carboplatin Hexal
    Hexal, Germany


  • Carboplatin Hospira
    Hospira, Greece; Hospira Nordic, Sweden


  • Carboplatin Injection
    Hospira, Australia; Teva USA, United States; PfizerPerth, Australia


  • Carboplatin Kalbe
    Kalbe, Indonesia


  • Carboplatin Mayne
    Hospira, Norway; Hospira Nordic, Denmark; Mayne, Iceland


  • Carboplatin Meda
    Meda, Denmark; Meda, Sweden


  • Carboplatin Merck
    Merck Génériques, Tunisia


  • Carboplatin onkovis
    Onkovis, Germany


  • Carboplatin Pfizer
    Pfizer, Austria; Pfizer, Denmark; Pfizer, Finland; Pfizer, Iceland; Pfizer, New Zealand; Pfizer, Serbia; Pfizer, Singapore


  • Carboplatin Pharmacia
    Pfizer, Vietnam


  • Carboplatin Pliva
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia


  • Carboplatin Sandoz
    Sandoz, Germany


  • Carboplatin Sindan
    Sindan, Romania


  • Carboplatin Teva
    Teva, Poland; Teva, Sweden


  • Carboplatin
    Akorn, United States; APP, United States; Bedford, United States; Ebewe, United States; Fresenius Kabi Oncology, United States; Generamedix, United States; Hospira, Canada; Hospira, United Kingdom; Hospira, United States; Mayne, Ireland; Mayne, United States; Pfizer, Estonia; Pfizer, Croatia (Hrvatska); Pfizer, Latvia; Pfizer, Poland; Pharmachemie, Taiwan; Pharmachemie, United States; Pharmacia, Bulgaria; Pliva, United States; Sandoz, United States; Serum Institute, Georgia; Spectrum Pharmaceuticals, United States; Sun, United States; Teva, Israel; Teva, Norway; Watson, United States


  • Carboplatina Aps
    Aps, Portugal


  • Carboplatine Actavis
    Actavis, France


  • Carboplatine Aguettant
    Aguettant, France; Aguettant, Tunisia


  • Carboplatine Ebewe
    Ebewe, Romania


  • Carboplatine G Gam
    Sandoz, France


  • Carboplatine Hospira
    Hospira, Belgium; Hospira, France


  • Carboplatine Intas
    Intas, France


  • Carboplatine Mayne
    Hospira, Luxembourg


  • Carboplatine Mylan
    Mylan, France


  • Carboplatine Teva
    Teva Santé, France


  • Carboplatine Winthrop
    Sanofi-Aventis, France


  • Carboplatine
    Accord Healthcare, Netherlands; Ebewe, Netherlands; Hospira, Netherlands; Sandoz, Netherlands


  • Carboplatin-GRY
    Teva-Gry, Germany


  • Carboplatin-Medac
    medac, Luxembourg


  • Carboplatin-Mepha
    Mepha Pharma, Switzerland


  • Carboplatino Aguettant
    Serra Pamies, Spain


  • Carboplatino Delta Farma
    Delta Farma, Argentina


  • Carboplatino Dosa
    Dosa, Argentina


  • Carboplatino Ebewe
    Ebewe, Italy


  • Carboplatino Ferrer Farma
    Ferrer, Spain


  • Carboplatino Filaxis
    Filaxis, Argentina


  • Carboplatino Hospira
    Hospira, Italy


  • Carboplatino Ivax
    Ivax, Argentina


  • Carboplatino Labesfal
    Labesfal, Spain


  • Carboplatino Martian
    LKM, Argentina


  • Carboplatino Microsules
    Microsules, Argentina


  • Carboplatino Pfizer
    Pfizer, Italy


  • Carboplatino Pharmacia
    Pharmacia, Spain


  • Carboplatino Raffo
    Raffo, Argentina


  • Carboplatino ratiopharm
    Ratiopharm, Spain; Ratiopharm, Italy


  • Carboplatino Rontag
    Rontag, Argentina


  • Carboplatino RU
    World Pharma, Peru


  • Carboplatino Servycal
    Servycal, Argentina; Servycal, Peru


  • Carboplatino Sidus
    Sidus, Argentina


  • Carboplatino Teva
    Teva, Spain; Teva, Italy


  • Carboplatino Varifarma
    Varifarma, Argentina


  • Carboplatino Vegal
    Vegal, Spain


  • Carboplatino
    Baxter, Chile; Biolatina, Chile; Kampar, Chile; Pfizer, Chile; Pfizer, Colombia; Pfizer, Ecuador; Pfizer, Peru; Royal Pharma, Chile; Tecnofarma, Colombia; Teva, Argentina


  • Carboplatin-ratiopharm
    Ratiopharm, Germany


  • Carboplatin-Teva
    Med, Turkey; Teva, Czech Republic; Teva, Hungary; Teva, Latvia; Teva Pharma, Switzerland


  • Carboplatinum Cytosafe-Pharmacia
    Pharmacia, Luxembourg


  • Carboplatinum
    Pfizer, Belgium


  • Carbo-PT Ebewe
    OncoCorp, Germany


  • Carbosin
    Chemipharm, Greece; Combiphar, Indonesia; Emporio, Slovenia; Er-Kim, Turkey; Med, Turkey; Pharmachemie, Indonesia; Pharmachemie, Sri Lanka; Pharmachemie, Malaysia; Pharmachemie, Netherlands; Pharmachemie, Peru; Pharmachemie, South Africa; Teva, Belgium


  • Carbox
    Medicopharm, Germany


  • Carboxtie
    Bioprofarma, Argentina


  • Cicloplatin
    Lachema, Romania


  • Cobalmin
    AC Farma, Peru


  • Cycloplatin
    Lachema, Serbia; Pliva, Bulgaria; Pliva, Czech Republic; Pliva, Hungary; Pliva, Serbia; Pliva, Russian Federation; Pliva, Slovakia; Pliva Lachema, Poland


  • Cytocarb
    Unifarma, Latvia


  • Emorzim
    Pharmacia, Greece


  • Eurocarboplatin
    Lapharm, Germany


  • Haemato-carb
    Haemato, Germany


  • Kemocarb
    Dabur, Georgia; Dabur, India; Dabur, Myanmar; Dabur, Philippines


  • Megaplatin
    Genepharm, Greece; Genepharm, Tunisia


  • Neocarbo
    NeoCorp, Germany


  • Omilipis
    Richmond, Argentina; Richmond, Peru


  • Oncocarb
    Biotoscana, Chile; Biotoscana, Colombia


  • Oncocarbin
    Koçak, Turkey; Sun, Myanmar


  • Oplat
    Nolver, Venezuela


  • O-Plat
    Richmond, Peru


  • P&U Carboplatin
    Pfizer, South Africa


  • ParaGal
    Galenika, Serbia


  • Paraplatin
    Bristol-Myers Squibb, United Arab Emirates; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Estonia; Bristol-Myers Squibb, Egypt; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iraq; Bristol-Myers Squibb, Iran; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Jordan; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Qatar; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Saudi Arabia; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Syria; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Yemen; Bristol-Myers Squibb, South Africa; PharmaSwiss, Croatia (Hrvatska)


  • Paraplatin (veterinary use)
    Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, United Kingdom


  • Paraplatine
    Bristol-Myers Squibb, France; Bristol-Myers Squibb, Tunisia


  • Platamine
    Pfizer, Brazil


  • Platinwas
    Chiesi, Spain


  • Ribocarbo
    Hikma, Germany


  • Tecnocarb
    Zodiac, Brazil


  • Womastin
    Khandelwal, Myanmar

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 12 May 2010

Devisol




Devisol may be available in the countries listed below.


Ingredient matches for Devisol



Calcifediol

Calcifediol monohydrate (a derivative of Calcifediol) is reported as an ingredient of Devisol in the following countries:


  • Poland

International Drug Name Search

Sunday, 9 May 2010

Invirase


Invirase is a brand name of saquinavir, approved by the FDA in the following formulation(s):


INVIRASE (saquinavir mesylate - capsule; oral)



  • Manufacturer: HOFFMANN LA ROCHE

    Approval date: December 6, 1995

    Strength(s): EQ 200MG BASE [RLD]

INVIRASE (saquinavir mesylate - tablet; oral)



  • Manufacturer: ROCHE

    Approval date: December 17, 2004

    Strength(s): EQ 500MG BASE [RLD]

Has a generic version of Invirase been approved?


No. There is currently no therapeutically equivalent version of Invirase available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Invirase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Invirase.

See also...

  • Invirase Consumer Information (Drugs.com)
  • Invirase Consumer Information (Wolters Kluwer)
  • Invirase Consumer Information (Cerner Multum)
  • Invirase Advanced Consumer Information (Micromedex)
  • Invirase AHFS DI Monographs (ASHP)
  • Saquinavir Consumer Information (Wolters Kluwer)
  • Saquinavir Mesylate Consumer Information (Wolters Kluwer)
  • Saquinavir Consumer Information (Cerner Multum)
  • Saquinavir Advanced Consumer Information (Micromedex)
  • Saquinavir AHFS DI Monographs (ASHP)